early response to Combination Action oN Active Reaction to Incetin agent and SGLT2i

early response to Combination Action oN Active Reaction to Incetin agent and SGLT2i - CANARIS

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031394

Enrollment

Registered

2018-02-20

Start date

2015-03-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 daibetes mellitus

Interventions

Before administration of SGLT2 inhibitor, after administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: In hospitalized type 2 diabetic patients who are not receiving SGLT-2 inhibitor and incretin agonist (DPP 4 inhibitor, GLP-1 inhibitor)

Exclusion criteria

Exclusion criteria: Patients with a history of hypersensitivity to the study drug Patients with severe ketosis, diabetic coma or precoma, type 1 diabetes Patients with severe infections, before and after surgery, serious trauma Pregnant or lactating women and pregnant women Patients who the doctor judged unsuitable for research participation Explain participation of this research, patients who can not obtain consent

Design outcomes

Primary

Measure	Time frame
Blood glucose level, insulin level, glucagon level, FFA	—

Countries

Japan

Contacts

Public ContactOKAHATA SUMIE

Toho University Ohashi Medical Center Division of Diabetes and Metabolism

sokahata-tky@umin.ac.jp03-3468-1251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026